RTI Surgical (NASDAQ:RTIX) had its target price hoisted by investment analysts at Cantor Fitzgerald from $4.00 to $6.00 in a report released on Friday, BenzingaRatingsTable reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 33.33% from the stock’s current price.
Several other research firms also recently commented on RTIX. ValuEngine downgraded shares of RTI Surgical from a “buy” rating to a “hold” rating in a report on Wednesday. Zacks Investment Research upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, December 27th. Finally, TheStreet lowered RTI Surgical from a “c-” rating to a “d+” rating in a research note on Thursday, October 24th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $6.33.
RTIX traded up $0.04 during trading on Friday, hitting $4.50. 49,088 shares of the company traded hands, compared to its average volume of 1,339,894. RTI Surgical has a one year low of $1.77 and a one year high of $6.15. The stock’s fifty day moving average is $2.53 and its 200 day moving average is $2.97. The firm has a market cap of $332.90 million, a P/E ratio of 37.50 and a beta of 1.40.
RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings data on Thursday, October 31st. The medical equipment provider reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). RTI Surgical had a negative net margin of 3.72% and a positive return on equity of 1.75%. The business had revenue of $76.13 million for the quarter.
Hedge funds have recently modified their holdings of the stock. Charles Schwab Investment Management Inc. grew its holdings in shares of RTI Surgical by 4.3% during the second quarter. Charles Schwab Investment Management Inc. now owns 137,040 shares of the medical equipment provider’s stock worth $583,000 after purchasing an additional 5,594 shares in the last quarter. Dupont Capital Management Corp increased its position in shares of RTI Surgical by 4.8% in the third quarter. Dupont Capital Management Corp now owns 124,842 shares of the medical equipment provider’s stock worth $356,000 after purchasing an additional 5,697 shares during the last quarter. Rhumbline Advisers raised its stake in RTI Surgical by 8.7% in the third quarter. Rhumbline Advisers now owns 90,243 shares of the medical equipment provider’s stock valued at $257,000 after purchasing an additional 7,253 shares in the last quarter. Parametric Portfolio Associates LLC raised its stake in RTI Surgical by 20.5% in the second quarter. Parametric Portfolio Associates LLC now owns 47,661 shares of the medical equipment provider’s stock valued at $203,000 after purchasing an additional 8,104 shares in the last quarter. Finally, Wells Fargo & Company MN raised its stake in RTI Surgical by 11.6% in the second quarter. Wells Fargo & Company MN now owns 113,200 shares of the medical equipment provider’s stock valued at $480,000 after purchasing an additional 11,796 shares in the last quarter. Institutional investors own 60.06% of the company’s stock.
About RTI Surgical
RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.
See Also: How Does the Quiet Period Work?
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.